Bristol-Myers Squibb CompanyBMY
NYSE•Healthcare•Drug Manufacturers - General
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $48.48B, growing 1.8% year-over-year. TTM net income stood at $7.28B (34.2% growth). Quarterly EBITDA was $4.40B and operating income was $3.80B. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze BMY growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters